James M. Mock, Chief Financial Officer at Moderna, Inc. (MRNA), sold 34,836 shares at $134.49 ($4.7M) on 2026-09-10, disclosed to the SEC on 2026-09-14.
Scheduled sale ($4.7M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $134.49 | 15,000 | $2.0M | 43.1% |
| 2 | $134.49 | 19,836 | $2.7M | 56.9% |
| Total | $134.49 avg | 34,836 | $4.7M | 100% |
| Filing → |
| MRNA | SELL | 2024-08-30 | $13K | — | Filing → |
| MRNA | SELL | 2024-08-29 | $210K | — | Filing → |
| MRNA | SELL | 2024-07-09 | $163K | — | Filing → |